Abstract:Motivation: The process of placing new drugs into the market is time-consuming, expensive and complex. The application of computational methods for designing molecules with bespoke properties can contribute to saving resources throughout this process. However, the fundamental properties to be optimized are often not considered or conflicting with each other. In this work, we propose a novel approach to consider both the biological property and the bioavailability of compounds through a deep reinforcement learning framework for the targeted generation of compounds. We aim to obtain a promising set of selective compounds for the adenosine A2A receptor and, simultaneously, that have the necessary properties in terms of solubility and permeability across the blood-brain barrier to reach the site of action. The cornerstone of the framework is based on a recurrent neural network architecture, the Generator. It seeks to learn the building rules of valid molecules to sample new compounds further. Also, two Predictors are trained to estimate the properties of interest of the new molecules. Finally, the fine-tuning of the Generator was performed with reinforcement learning, integrated with multi-objective optimization and exploratory techniques to ensure that the Generator is adequately biased. Results: The biased Generator can generate an interesting set of molecules, with approximately 85% having the two fundamental properties biased as desired. Thus, this approach has transformed a general molecule generator into a model focused on optimizing specific objectives. Furthermore, the molecules' synthesizability and drug-likeness demonstrate the potential applicability of the de novo drug design in medicinal chemistry. Availability and implementation: All code is publicly available in the https://github.com/larngroup/De-Novo-Drug-Design. Supplementary information: Supplementary data are available at Bioinformatics online.

<i>De novo</i> drug design framework based on mathematical programming method and deep learning model

De novo drug design framework based on mathematical programming method and deep learning model

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

Deep Learning Approaches for &lt;italic&gt;de Novo&lt;/italic&gt; Drug Design: an Overview

Deep learning approaches for <i>de novo</i> drug design: An overview

De Novo Structure-Based Drug Design Using Deep Learning

Deep learning approaches for de novo drug design: An overview

De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment

Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules

Prospective de novo drug design with deep interactome learning

Structure-based <i>de novo</i> drug design using 3D deep generative models

De novo drug design based on Stack-RNN with multi-objective reward-weighted sum and reinforcement learning

Deep Generative Models in De Novo Drug Molecule Generation

Graph-based generative models for de Novo drug design

Optimizing blood-brain barrier permeation through deep reinforcement learning for de novo drug design

Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model

Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models

Advances in De Novo Drug Design: From Conventional to Machine Learning Methods

De novo drug design using reinforcement learning with graph-based deep generative models

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

Comprehensive assessment of deep generative architectures for de novo drug design